אבאמיס
glaxo smith kline (israel) ltd - fluticasone furoate - ספריי - fluticasone furoate 27.5 mcg/dose - fluticasone furoate - fluticasone - avamys (fluticasone furoate) nasal spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older.
רלבר אליפטה 22 184 מקג
glaxo smith kline (israel) ltd - fluticasone furoate; vilanterol as trifenatate - אבקה לשאיפה - vilanterol as trifenatate 22 mcg; fluticasone furoate 184 mcg - fluticasone furoate
רלבר אליפטה 22 92 מקג
glaxo smith kline (israel) ltd - fluticasone furoate; vilanterol as trifenatate - אבקה לשאיפה - vilanterol as trifenatate 22 mcg; fluticasone furoate 92 mcg - fluticasone furoate
טרלג'י אליפטה 22 55 92 מקג
glaxo smith kline (israel) ltd - fluticasone furoate; umeclidinium as bromide; vilanterol as trifenatate - vilanterol as trifenatate 22 mcg/inh; umeclidinium as bromide 55 mcg/inh; fluticasone furoate 92 mcg/inh - vilanterol, umeclidinium bromide and fluticasone furoate
טרלג'י אליפטה 1845522 מקג
glaxo smith kline (israel) ltd - fluticasone furoate; umeclidinium as bromide; vilanterol as trifenatate - vilanterol as trifenatate 22 mcg/inh; umeclidinium as bromide 55 mcg/inh; fluticasone furoate 184 mcg/inh - vilanterol, umeclidinium bromide and fluticasone furoate
פלוטיפורם 505
rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.
פלוטיפורם 1255
rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.
פלוטיפורם 25010
rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.
פליקסוטייד דיסקוס 500 מקג
glaxo smith kline (israel) ltd - fluticasone propionate - אבקה לשאיפה - fluticasone propionate 500 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma. symptomatic treatment of chronic obstructive pulmonary disease.
פליקסוטייד דיסקוס 250 מקג
glaxo smith kline (israel) ltd - fluticasone propionate - אבקה לשאיפה - fluticasone propionate 250 mcg - fluticasone - fluticasone - prophylactic management of all grades of asthma. symptomatic treatment of chronic obstructive pulmonary disease.